Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases-Reference-Cited by-同舟云学术

Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases

Published:2013-05 Issue:8 Volume:49 Page:1993-1999
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Adank Muriel A.,Verhoef Senno,Oldenburg Rogier A.,Schmidt Marjanka K.,Hooning Maartje J.,Martens John W.M.,Broeks Annegien,Rookus Matti,Waisfisz Quinten,Witte Birgit I.,Jonker Marianne A.,Meijers-Heijboer Hanne

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Low-penetrance susceptibility to breast cancer due to CHEK2∗1100delC in noncarriers of BRCA1 or BRCA2 mutations;Meijers-Heijboer;Nat Genet,2002

2. CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?;Antoni;Nat Rev Cancer,2007

3. CHEK2∗1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies;Am J Hum Genet,2004

4. Testing for CHEK2 in the cancer genetics clinic: ready for prime time?;Narod;Clin Genet,2010

5. Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2∗1100delC in 1828 bilateral breast cancers and 7030 controls;Fletcher;Cancer Epidemiol Biomarkers Prev,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families;Genetics in Medicine;2024-09

2. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families;The Breast;2024-06

3. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario;European Journal of Medical Research;2024-03-20

4. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families;The Breast;2024-02

5. A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients;Scientific Reports;2021-07-20